GL1X · GenesisL1 explorer

Research workbench

Kelch domain of human KEAP1 bound to NRF2 linear peptide, ac-gdeetge- NH2

Analyse Kelch domain of human KEAP1 bound to NRF2 linear peptide, ac-gdeetge- NH2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7K2D
Type
protein
Length
570 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Kelch-like ech-associated protein 1; NRF2 linear peptide, ACE-gdeetge-NH2
UniProt
Q14145
Ligands
ACE, NH2
Pockets
8 · best druggability 0.74

Structure

x-ray diffraction · 3 distinct chains · 0% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AKelch-like ech-associated protein 1protein2830% helix, 52% strandQ14145
BKelch-like ech-associated protein 1protein2800% helix, 53% strandQ14145
PNRF2 linear peptide, ACE-gdeetge-NH2protein70% helix, 0% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains B, P
  • NH2 · Amino group · ion · chains B, P

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14160.740.8451empty
23690.720.8436empty
31650.650.8523empty
41330.440.7620empty
51290.410.7518empty

Interfaces

2 interfaces between chains.

  • A–B · 690 Ų buried · 5 hydrogen bonds · protein-protein
  • B–P · 472 Ų buried · 15 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7K2D · Kelch domain of human KEAP1 bound to Nrf2 linear peptide, Ac-GDEETGE-NH2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.